Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical… CISION PRNewswireApril 27, 2026
The EXCEL – First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease PARIS, April 27, 2026 /PRNewswire/ — A new study has established that treatment… CISION PRNewswireApril 27, 2026
Press ReleaseCONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026 LONDON, April 27, 2026 /PRNewswire/ — Concept Medical Inc., today announced the… CISION PRNewswireApril 27, 2026
BusinessPress ReleaseThe 7th "Design Licensing and Business (DLAB) Support Scheme" Launching Ceremony of DLAB Hong Kong Pavilion in HK Int'l Licensing Show 2026 39 Local Design Companies Showcase New Momentum in Hong Kong’s Creative Industry … CISION PRNewswireApril 27, 2026
Like attracts like, kindred spirits respond in harmony, Jointly forge a new future of global intelligent mobility BEIJING, April 27, 2026 /PRNewswire/ — All New GAC, Going Global! On… CISION PRNewswireApril 27, 2026
Press ReleaseNYSE Content Update: Former NASA Head to Ring Closing Bell for NYSE Space Summit NYSE issues a pre-market daily advisory direct from the trading floor. NEW… CISION PRNewswireApril 27, 2026
Press ReleaseBlueFocus CEO Fei Pan on Re-Architecting Marketing Around AI BEIJING, April 27, 2026 /PRNewswire/ — For BlueFocus, AI is no longer a… CISION PRNewswireApril 27, 2026
Press ReleaseDreame NEXT North America Launch: Three Innovations Set to Shape the Future of the Smart Yard SAN FRANCISCO, April 27, 2026 /PRNewswire/ — From April 27 to 30,… CISION PRNewswireApril 27, 2026
